{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F063c0699-3770-4df2-ab5b-5b4393bc37a0","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"An interview with Matthew R Smith, MD, PhD \u2014 Management of Prostate Cancer\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/063c0699-3770-4df2-ab5b-5b4393bc37a0\"></iframe>","title":"An interview with Matthew R Smith, MD, PhD \u2014 Management of Prostate Cancer","description":"\n        <p>Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/OncologyTodayASCOProstate24\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/12a3fbb1-d1da-4d78-b339-9e2336e95115/cover.jpg"}